Evidence map›Paper›PMID 40166614›Full record

ArticleSynthetic and systems biotechnology2025

System-level characterization of engineered and evolved formatotrophic

Suzan Yilmaz, Boas Kanis, Rensco A H Hogers, Sara Benito-Vaquerizo, Jörg Kahnt, Timo Glatter, Beau Dronsella, Tobias J Erb, Maria Suarez-Diez, Nico J Claassens

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Synthetic and systems biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. FormatotrophicSynthetic and systems biotechnology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Suzan YilmazLaboratory of Microbiology, Wageningen University, Wageningen, the Netherlands.
Boas KanisLaboratory of Systems and Synthetic Biology, Wageningen University, Wageningen, the Netherlands.
Rensco A H HogersLaboratory of Systems and Synthetic Biology, Wageningen University, Wageningen, the Netherlands.
Sara Benito-VaquerizoLaboratory of Systems and Synthetic Biology, Wageningen University, Wageningen, the Netherlands.
Jörg KahntCore Facility for Mass Spectrometry and Proteomics, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany.
Timo GlatterCore Facility for Mass Spectrometry and Proteomics, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany.
Beau DronsellaBiochemistry and Synthetic Metabolism, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany.
Tobias J ErbBiochemistry and Synthetic Metabolism, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany.
Maria Suarez-DiezLaboratory of Systems and Synthetic Biology, Wageningen University, Wageningen, the Netherlands.
Nico J ClaassensLaboratory of Microbiology, Wageningen University, Wageningen, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One-carbon compounds, such as formate, are promising and sustainable feedstocks for microbial bioproduction of fuels and chemicals. Growth of

Indexed as

C1-assimilationEscherichia coliFormateMetabolic modellingReductive glycine pathway

Identifiers

PMID40166614
PMCPMC11957790

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.